Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an Optimal Approach to Return of Results for Families Undergoing Next-generation Sequencing for Prenatal Diagnosis.

NCT02255825 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT02255825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02255825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an Optimal Approach to Return of Results for Families Undergoing Next-generation Sequencing for Prenatal Diagnosis.
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2014
Completion date
June 4, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major fetal anomaly